MedTrace Logo

A Study of Hypertonic Saline for Infants Hospitalized With Bronchiolitis

NCT01488448 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 227

Last updated 2017-02-02

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine if nebulized hypertonic saline (or extra salty water mist) helps infants less than 12 months old hospitalized with bronchiolitis (or bad chest colds) get better enough to be discharged from the hospital sooner than those infants given nebulized normal saline (or regular salty water mist).

Conditions

  • Bronchiolitis

Interventions

DRUG

3% sodium chloride

4 milliliters delivered via nebulizer with 5 Liters O2 flow every 4 hours until discharge

DRUG

0.9% sodium chloride

4 milliliters delivered via nebulizer with 5 Liters O2 flow every 4 hours until discharge

Sponsors & Collaborators

  • Montefiore Medical Center

    lead OTHER

Principal Investigators

  • Alyssa H Silver, MD · Albert Einstein College of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Max Age
12 Months
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-11-30
Primary Completion
2014-07-31
Completion
2015-08-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01488448 on ClinicalTrials.gov